Chemical formula: C₂₆H₂₅ClN₂O₃ Molecular mass: 448.941 g/mol PubChem compound: 443894
Tolvaptan is a selective vasopressin V2-receptor antagonist that specifically blocks the binding of arginine vasopressin (AVP) at the V2-receptor of the distal portions of the nephron. Tolvaptan affinity for the human V2-receptor is 1.8 times that of native AVP.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C03XA01 | Tolvaptan | C Cardiovascular system → C03 Diuretics → C03X Other diuretics → C03XA Vasopressin antagonists |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| JINARC Tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| SAMSCA Tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Tolvaptan is an active ingredient of these brands:
Australia (AU)Netherlands (NL)New Zealand (NZ)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
